| Literature DB >> 17683610 |
Jamie A Ruffing1, Jeri W Nieves, Marsha Zion, Susan Tendy, Patricia Garrett, Robert Lindsay, Felicia Cosman.
Abstract
PURPOSE: To determine the influence of menstrual irregularity, oral contraceptive use and other factors on bone mineral density (BMD) and bone size at different skeletal sites in 135 college-aged fit women.Entities:
Year: 2007 PMID: 17683610 PMCID: PMC1997123 DOI: 10.1186/1743-7075-4-17
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Descriptive variables for Caucasian women (values are mean (standard deviation) unless otherwise stated)
| Variable | All Women (n = 107) | Women with Normal Cycles (n = 81) | Women with Amenorrhea/Oligomenorrhea (n = 25) | Women on Oral Contraceptives (n = 12) | Women never on Oral Contraceptive (n = 95) |
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Age | 18.4 (± 0.8) | 18.4 (± 0.8) | 18.6 (± 0.9) | 18.6 (± 1.0) | 18.4 (± 0.7) |
| Age of Menarche (years) | 12.8 (± 1.2) | 12.6 (± 1.1) | 13.6 (± 0.9) | 12.5 (± 1.2) | 12.9 (± 1.1) |
| BMI (kg/mg2) | 23.0 (± 2.3) | 23.3 (± 2.4) | 22.6 (± 2.0) | 22.8 (± 1.8) | 23.2 (± 2.4) |
| Height (inches) | 65.7 (± 2.4) | 65.6 (± 2.5) | 66.1 (± 1.8) | 64.6 (± 3.0) | 65.8 (± 2.3) |
| Weight (pounds) | 142 (± 17) | 142.4 (± 17.8) | 140.6 (± 15.3) | 135.3 (± 12.8) | 142.6 (± 17.4) |
| Army Physical Fitness Test (APFT 0–300) | 207.8 (± 40.9) | 206.0 (± 39.3) | 215.1 (± 39.3) | 188.3 (± 52.3) | 211.8 (± 36.6) |
| Run score (range 0–100) | 74 (± 22) | 72.3 (± 22.1) | 77.7 (± 22.0) | 59.9 (± 25.7) | 76.1 (± 20.9) |
| Calcium Intake (mg/day) | 1074 (± 463) | 1167 (± 459) | 1014 (± 389) | 937 (± 419) | 1142 (± 449) |
| Exercise (hrs/week) %, (n) | |||||
| 1–3 | 3.0 (4) | 2.9 (3) | 3.4 (1) | 0 (0) | 1 (1) |
| 4–6 | 19.5 (26) | 19.4 (38) | 20.7 (6) | 41.7 (5) | 15.6 (15) |
| 7–10 | 33.8 (45) | 36.9 (24) | 24.1 (7) | 33.3 (4) | 38.5 (37) |
| 11+ | 43.6 (58) | 40.8 (42) | 51.7 (15) | 25.0 (3) | 44.8 (43) |
| Milk (glass/day) %, (n) | |||||
| 0 | 11.3 (15) | 10.7 (11) | 13.8 (15) | 8.3 (1) | 11.5 (11) |
| <1 | 29.3 (39) | 23.3 (24) | 48.3 (14) | 25.0 (3) | 25.0 (24) |
| 1–2 | 46.6 (62) | 52.4 (54) | 27.6 (8) | 50.0 (6) | 49.0 (47) |
| 3+ | 12.8 (17) | 13.6 (14) | 10.3 (3) | 16.7 (2) | 14.6 (14) |
| Caffeinated Drink/Day %, (n) | |||||
| None | 24.1(32) | 22.3 (23) | 27.6 (8) | 33.3 (4) | 20.8 (20) |
| 1–3 | 69.2 (92) | 70.9 (73) | 65.5 (19) | 58.3 (7) | 70.8 (68) |
| 3+ | 6.8 (9) | 6.8 (7) | 6.9 (2) | 8.3 (1) | 8.3 (8) |
| Alcohol Consumption %, (n) | |||||
| Less than once a month | 66.9 (91) | 70.9 (73) | 55.2 (16) | 66.7 (8) | 64.6 (62) |
| 1–3 times a month | 21.3 (28) | 18.4 (19) | 34.5 (10) | 16.7 (2) | 24.0 (23) |
| 1–2 times a week | 8.8 (12) | 8.7 (9) | 10.3 (3) | 8.3 (1) | 11.5 (11) |
| >3 times a week | 1.5 (2) | 1.9 (2) | 0.0 (0) | 8.3 (1) | 0 (0) |
| Smokers %, (n) | 3.0 (4) | 2.9 (3) | 3.4 (1) | 8.3 (1) | 2.2 (2) |
| History of Fracture (% yes); n | 34.1 (46) | 38.8 (40) | 24.1 (7) | 33.3 (4) | 37.5 (36) |
*p < 0.05 versus women with normal cycles
# p < 0.05 versus women never on oral contraceptives
Figure 1The impact of menstrual function on bone mass and size. Menstrual function was defined as normal (≥ 10 cycles/year) versus oligomenorrhea/amenorrhea (≤ 9 cycles/year). Bone mineral density was measured at the spine, hip and heel; and at the tibia, bone mineral content, cortical thickness and endosteal circumference were determined. All values are mean ± standard errors.
Figure 2The impact of oral contraceptive use on bone mass and size. Oral contraceptive use was defined as OC use for at least three months versus never users. Bone mineral density was measured in these two groups at the spine, hip and heel; at the tibia, bone mineral content, cortical thickness and periosteal circumference were measured. All values are mean ± standard errors.
Multiple linear regression models for bone density in Caucasian females
| Calcaneal BMD | 0.118 | +0.002(weight) | +0.021(milk intake) | +0.049(current OC use) | |
| (SE) | 0.080 | 0.001 | 0.009 | 0.025 | |
| 0.141 | 0.001 | 0.024 | 0.052 | ||
| Spine BMD | 0.461 | +0.003(weight) | +0.035(cycles/year) | +0.062(current OC use) | +0.025(exercise) |
| (SE) | 0.125 | 0.001 | 0.013 | 0.036 | 0.014 |
| 0.001 | 0.001 | 0.011 | 0.087 | 0.078 | |
| Total Hip BMD | 0.617 | +0.003(weight) | -0.049(fracture hx) | +0.035(cycle/year) | +0.032 (exercise) |
| (SE) | 0.001 | 0.001 | 0.022 | 0.013 | 0.014 |
| 0.001 | 0.001 | 0.030 | 0.010 | 0.021 | |
Multiple linear regression table for Caucasian female tibial parameters
| Mineral Content | 54.836 | +10.63(cycles/year) | +1.063(weight) | +0.395 (run) | +6.157 (exercise) |
| (SE) | (27.03) | (2.87) | (0.15) | (0.12) | (3.39) |
| (0.095) | (0.001) | (0.001) | (0.002) | (0.073) | |
| Cortical Thickness | 2.141 | +0.355(cycles/year) | +0.011 (run score) | +0.009 (weight) | |
| (SE) | (0.696) | (0.077) | (0.003) | (0.004) | |
| (0.003) | (0.001) | (0.00) | (0.034) | ||
| Periosteal Circumference | 42.42 | +0.135 (weight) | +2.496 (OC use) | ||
| (SE) | (4.42) | (0.027) | (1.377) | ||
| (0.01) | (0.001) | (0.07) | |||